Skip to main content
OpenTrials

Clinical trial condition

Peritoneal Neoplasms

Explore clinical trials studying Peritoneal Neoplasms. Study availability and eligibility vary by location and protocol.

54 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Peritoneal Neoplasms trial results

Recruiting

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

NCT06906341

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +25 more
Locations
  • 004 Birmingham, Alabama, United States
  • 150 Palo Alto, California, United States
  • 014 San Francisco, California, United States
  • 544 Fort Myers, Florida, United States
View all 49 locations
View Trial Details
Recruiting

Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy

NCT06351475

Conditions
Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations
  • Institut régional du Cancer de Montpellier Montpellier, France
  • La Pitié Salpetriere hospital Paris, France
  • Lariboisière hospital Paris, France
  • Saint Louis hospital Paris, France
View Trial Details
Recruiting

MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)

NCT04111978

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +18 more
Locations
  • Krankenhaus der Barmherzigen Brüder Graz Graz, Austria
  • Medizinische Universität Graz Graz, Austria
  • Medizinische Universität Innsbruck Innsbruck, Austria
  • Landeskrankenhaus Hochsteiermark Leoben Leoben, Austria
View all 53 locations
View Trial Details
Completed

Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

NCT00086567

Conditions
Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +25 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Evanston Northwestern University Hospital Evanston, Illinois, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Completed

Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

NCT03740165

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +22 more
Locations
  • University of Alabama at Birmingham (UAB) ( Site 0036) Birmingham, Alabama, United States
  • University of Arizona Cancer Center ( Site 0074) Tucson, Arizona, United States
  • Disney Family Cancer Center ( Site 0042) Burbank, California, United States
  • Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077) Oakland, California, United States
View all 227 locations
View Trial Details
Completed

An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

NCT01932125

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
Locations
  • Manipal Hospital Bangalore, Karnataka, India
  • HealthCare Global Enterprises Limited Banglore, Karnataka, India
  • Marthwada Regional Cancer Center & Research Institute Aurangabad, Maharashtra, India
  • MOC Cancer Care & Research Centre Mumbai, Maharashtra, India
View all 13 locations
View Trial Details

Related conditions